. "0923-7534" . "PET; Hodgkin lymphoma"@en . . . "2. C\u00EDlem studie je vyhodnocen\u00ED prediktivn\u00ED hodnoty metody PET po 4 cyklech chemoterapie BEACOOP u pacient\u016F s pokro\u010Dil\u00FDm stadiem Hodgkinsk\u00E9ho lymfomu za\u0159azen\u00FDch do studie HD 15 studijn\u00ED skupiny GHSG. 14 pacient\u016F z 50 l\u00E9\u010Den\u00FDch ve studii HD 15 m\u011Blo pozitivn\u00ED PET vy\u0161et\u0159en\u00ED po 4 cyklech chemoterapie. 13 z nich m\u011Blo inici\u00E1ln\u011B velkou masu lymfomu v mediastinu a dva z nich byli l\u00E9\u010Deni salvage terapi\u00ED a n\u00E1slednou transplantac\u00ED hematopoetick\u00FDch kmenov\u00FDch bun\u011Bk , nebo\u0165 tumor vykazoval neadekv\u00E1tn\u00ED odpov\u011B\u010F. Ve skupin\u011B s pozitivn\u00EDm PET vy\u0161et\u0159en\u00EDm po 4 cyklech chemoterapie m\u011Bla v\u011Bt\u0161ina pacient\u016F inici\u00E1ln\u011B velkou masu v mediastinu. Tento v\u00FDsledek podporuje teorii, \u017Ee velk\u00E1 mediastin\u00E1ln\u00ED masa je rizikov\u00FDm faktorem a vy\u017Eaduje intentivn\u00ED l\u00E9\u010Dbu. Nicm\u00E9n\u011B, vzhledem k dosud n\u00EDzk\u00E9mu po\u010Dtu pacient\u016F a kr\u00E1tk\u00E9 dob\u011B sledov\u00E1n\u00ED , nebyla dosud stanovena v\u00FDpov\u011Bdn\u00ED hodnota PET jako prognostick\u00E9ho faktoru u t\u011Bchto n\u00E1lez\u016F."@cs . "14 out of 50 pts treated within HD 15 study GHSG had positive PET scan after 4 cycles of the chemoterapy. 13 of these had initially a large mediastinal mass and two of them were trated by salvage therapy with high-dose therapy with autologous stem \u2013 cell support, because of tumor inadequate response. In our analysis we have found that PET4 positive patiens belong mostly to the group with initial large mediastinal mass. This fading supports again well known observation that the large mediastinal mas sis the high rist facto rand requires intensive type of treatment. However, considering still low number of patiens and short follow-up, any definite conclusion regarding the prognostic impact of this finding is pending."@en . . "14 out of 50 pts treated within HD 15 study GHSG had positive PET scan after 4 cycles of the chemoterapy. 13 of these had initially a large mediastinal mass and two of them were trated by salvage therapy with high-dose therapy with autologous stem \u2013 cell support, because of tumor inadequate response. In our analysis we have found that PET4 positive patiens belong mostly to the group with initial large mediastinal mass. This fading supports again well known observation that the large mediastinal mas sis the high rist facto rand requires intensive type of treatment. However, considering still low number of patiens and short follow-up, any definite conclusion regarding the prognostic impact of this finding is pending." . "3"^^ . "FDG-PET for assesment of early therapy response after 4 cycles of chemotherapy in advanced stage Hodgkin lymphoma" . . "FDG-PET for assesment of early therapy response after 4 cycles of chemotherapy in advanced stage Hodgkin lymphoma"@en . "FDG-PET ve vyhodnocen\u00ED \u010Dasn\u00E9 l\u00E9\u010Debn\u00E9 odpov\u011Bdi po 4 cyklech chemoterapie u pacient\u016F s pokro\u010Dil\u00FDm Hodgkinsk\u00FDm lymfomem"@cs . "1"^^ . . . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "19" . . "FDG-PET for assesment of early therapy response after 4 cycles of chemotherapy in advanced stage Hodgkin lymphoma"@en . . "Skopalov\u00E1, M." . "FDG-PET ve vyhodnocen\u00ED \u010Dasn\u00E9 l\u00E9\u010Debn\u00E9 odpov\u011Bdi po 4 cyklech chemoterapie u pacient\u016F s pokro\u010Dil\u00FDm Hodgkinsk\u00FDm lymfomem"@cs . "2008" . "RIV/00023884:_____/08:#0000020" . "FDG-PET for assesment of early therapy response after 4 cycles of chemotherapy in advanced stage Hodgkin lymphoma" . . "RIV/00023884:_____/08:#0000020!RIV09-MZ0-00023884" . . "P(NR8033)" . "1"^^ . "367762" . "Annals of Oncology" . "[D96FCF4103F9]" . . .